Kapoor M, Kaur KN, Saeed S, Shannawaz M, and Chandra A. Impact of COVID-19 on healthcare system in India: A system-atic review. J Public Health Res. 2023; 12: 22799036231186349.

Stirparo G, Oradini-Alacreu A, Migliori M , Villa GF, Botteri M , Fagoni N , Signorelli C , Sechi GM, Zoli A.Public health impact of the COVID-19 pandemic on the emergency healthcare system. J Public Health (Oxf). 2022; 44: e149-e152.

WHO Director-General's opening remarks at the media briefing on COVID-19: March 11, 2020. Available at: www.who.int/director-general. Accessed on 15/12/24.

World Health Organization (WHO), Coronavirus Disease (COVID-19) Pandemic Dashboard. Available at: www.who.int/emergencies/diseases/novel coronavirus 2019. Accessed on 31/12/24.

Adam D. COVID's true death toll: much higher than official records. Nature. 2022; 603: 562.

Moftakhar L, Moftakhar P, Piraee E, Ghaem H, Valipour A, Azarbakhsh H. Epidemiological characteristics and outcomes of COVID-19 in diabetic versus non-diabetic patients. Int J Diabetes Dev Ctries. 2021; 41: 383-388.

Goyal A, Gupta Y, Kalaivani M, Praveen PA, Ambekar S , and Tandon N. SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls. En-docr Pract. 2022; 28:191-198.

Kumar A , l Arora A , Sharma P , Anikhindi SA , Bansal N , Singla V , Khare S , and Srivastava A. Is diabetes mellitus as-sociated with mortality and severity of COVID 19? A meta-analysis. Diabetes Metab Syndr. 2020; 14: 535-545.

Sharma P, Behl T, Sharma N, Sing S, Grewal AS, Albarrati A, Albratty M, Meraya AM, and Bungau S. COVID-19 and dia-betes: Association intensify risk factors for morbidity and mortality. Biomed Biopharmacother. 2022; 151: 113089.

Zhu L, She Z-G, Cheng X, Qin J-J, Zhang X-J, Cai J, et al. Asso-ciation of blood glucose control and outcomes in patients with COVID-19 and pre-existing type-2 diabetes. Cell Metabol. 2020;31: 1068-77

Jindal R, Gupta M, Khan FR, and Gunjan Chaudhry G. Preva-lence of co morbidities and its association with mortality in Indian patients with COVID 19: A meta analysis. Indian J Anaesth, 2022; 66: 399-418.

Gupta A, Nayan N, Nair R, Kumar K, Joshi A, Sharma S, Singh J, and Kapoor R. Diabetes Mellitus and Hypertension Increase Risk of Death in Novel Corona Virus Patients Irre-spective of Age: a Prospective Observational Study of Co-morbidities and COVID-19 from India. SN Compr Clin Med. 2021; 3: 937-944.

Bailly L, Fabre R, Courjon J , Carls M, Dellamonica J and Pradier C. Obesity, diabetes, hypertension and severe out-comes among inpatients with coronavirus disease 2019: a nationwide study. Clin Microbiol Infect. 2022; 28: 114-123.

Hussain S, Baxi H, Jamali MC, Nisar N, Hussain MS. Burden of diabetes mellitus and its impact on COVID-19 patients: A me-ta-analysis of real-world evidence. Diabetes Metab Syndr. 2020; 14:1595-1602.

Roy DB, Gupta V Tomar S, Gupta G, Biswas A, Ranjan P, Baitha U, Pandey S, Prakash B, and Wig N. Epidemiology and Risk Factors of COVID-19- Related Mortality. Cureus. 2021; 13: e20072.

Wu Z, McGoogan JM. Characteristics of and important les-sons from the coronavirus disease 2019 (COVID-19) out-break in China: summary of a report of 72 314 cases from the Chinese center for disease control and prevention. J Am Med Assoc. 2020; 323: 1239-1242.

Nair AM, Gopalan S, Rajendran V, Varadaraj P, Marappa L, Pandurangan V, Madhavan S, Mani R, and Bhaskar E. Role of secondary sepsis in COVID-19 mortality: Observations on patients with preexisting diabetes mellitus and newly diag-nosed hyperglycemia. Monaldi Arch Chest Dis. 2022; 92: 2037. doi: 10.4081/monaldi.2022.2037.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, et al. Clinical course and risk factors for mortality of adult in patients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054-1062.

Hardy YH, Libhaber E, Ofori E, Amenuke DAY, Kontoh SA, Dankwah JA, Larsen-Reindorf R, Otu-Ansah C Hutton-Mensah K, Dadson E, Adamu S, Akyerekoh K, Sarfo FS, and Nkum B. Clinical and laboratory profile and outcomes of hospitalized COVID-19 patients with type 2 diabetes melli-tus in Ghana – A single-center study. Endocrinol Diab Metab. 2023; 6: e391.

Li G , Deng Q, Feng J , Li F ,Xiong N , and He Q. Clinical Characteristics of COVID-19 Patients with and without Diabe-tes in Wuhan Red Cross Hospital. J Diabetes Res. 2020; 2020: 1652403.

Akbariqomi M , Hosseini MS , Rashidiani J , Sedighian H, Biganeh H , Heidari R , Moghaddam MM, Farnoosh G , and Kooshki H. Clinical characteristics and outcome of hospital-ized COVID-19 patients with diabetes: A single-center, retro-spective study in Iran. Diabetes Res Clin Pract. 2020; 169: 108467.

Zhang Q , Wei Y, Chen M, Wan Q, and Chen X. Clinical analy-sis of risk factors for severe COVID-19 patients with type 2 diabetes. J Diabetes Complications. 2020; 34: 107666.

Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y, et al. Comor-bidity and its impact on 1590 patients with Covid-19 in Chi-na: A nationwide analysis. Eur Respir J. 2020; 55: 2000547. doi.org/10.1183/13993003.00547-2020.

Dallavalasa S , Tulimilli SV, Prakash J, Ramachandra R, Madhunapantula SV, and Veeranna RP. COVID-19: Diabetes Perspective—Pathophysiology and Management. Pathogens. 2023; 12:184.